Baxter International Inc. $BAX Shares Sold by Cullen Frost Bankers Inc.

Key Points

• Cullen Frost Bankers Inc. has reduced its stake in Baxter International by 45.9%, holding 50,854 shares worth $1.54 million after selling 43,173 shares in Q2.
• Baxter International reported $0.59 EPS for Q2, slightly missing the consensus estimate of $0.60, with revenues of $2.81 billion. The company's revenue is up 4.3% year-over-year.
• Institutional investors and hedge funds now own 90.19% of Baxter International's stock, indicating strong institutional interest in the company.

Cullen Frost Bankers Inc. lessened its stake in Baxter International Inc. (NYSE:BAX - Free Report) by 45.9% during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 50,854 shares of the medical instruments supplier's stock after selling 43,173 shares during the quarter. Cullen Frost Bankers Inc.'s holdings in Baxter International were worth $1,540,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the stock. Whittier Trust Co. raised its stake in Baxter International by 82.2% during the second quarter. Whittier Trust Co. now owns 3,202 shares of the medical instruments supplier's stock worth $97,000 after acquiring an additional 1,445 shares during the period. KLP Kapitalforvaltning AS raised its stake in Baxter International by 1.8% during the second quarter. KLP Kapitalforvaltning AS now owns 183,276 shares of the medical instruments supplier's stock worth $5,576,000 after acquiring an additional 3,300 shares during the period. Jeppson Wealth Management LLC raised its stake in Baxter International by 39.9% during the second quarter. Jeppson Wealth Management LLC now owns 8,392 shares of the medical instruments supplier's stock worth $254,000 after acquiring an additional 2,395 shares during the period. Public Employees Retirement System of Ohio raised its stake in Baxter International by 1.4% during the second quarter. Public Employees Retirement System of Ohio now owns 159,040 shares of the medical instruments supplier's stock worth $4,816,000 after acquiring an additional 2,226 shares during the period. Finally, Farmers & Merchants Investments Inc. raised its stake in Baxter International by 34.9% during the second quarter. Farmers & Merchants Investments Inc. now owns 21,255 shares of the medical instruments supplier's stock worth $644,000 after acquiring an additional 5,500 shares during the period. Institutional investors and hedge funds own 90.19% of the company's stock.

Baxter International Price Performance

NYSE BAX opened at $22.99 on Friday. Baxter International Inc. has a 52 week low of $21.33 and a 52 week high of $37.74. The company has a current ratio of 2.30, a quick ratio of 1.49 and a debt-to-equity ratio of 1.30. The stock has a market cap of $11.81 billion, a price-to-earnings ratio of -76.63, a price-to-earnings-growth ratio of 0.75 and a beta of 0.58. The company has a 50-day moving average price of $23.46 and a two-hundred day moving average price of $27.17.

Baxter International (NYSE:BAX - Get Free Report) last posted its earnings results on Thursday, July 31st. The medical instruments supplier reported $0.59 EPS for the quarter, missing the consensus estimate of $0.60 by ($0.01). The firm had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $2.82 billion. Baxter International had a positive return on equity of 16.96% and a negative net margin of 1.42%.Baxter International's revenue for the quarter was up 4.3% on a year-over-year basis. During the same quarter last year, the company posted $0.68 EPS. Baxter International has set its Q3 2025 guidance at 0.580-0.620 EPS. FY 2025 guidance at 2.420-2.520 EPS. Analysts forecast that Baxter International Inc. will post 2.48 EPS for the current year.

Wall Street Analyst Weigh In

BAX has been the topic of several research reports. UBS Group dropped their price objective on shares of Baxter International from $35.00 to $24.00 and set a "neutral" rating on the stock in a research note on Monday, August 4th. Citigroup dropped their price objective on shares of Baxter International from $34.00 to $32.00 and set a "neutral" rating on the stock in a research note on Wednesday, July 9th. Evercore ISI dropped their price objective on shares of Baxter International from $33.00 to $31.00 and set an "outperform" rating on the stock in a research note on Tuesday, October 7th. The Goldman Sachs Group lowered shares of Baxter International from a "buy" rating to a "neutral" rating and set a $25.00 price objective on the stock. in a research note on Friday, August 1st. Finally, Barclays decreased their target price on shares of Baxter International from $41.00 to $36.00 and set an "overweight" rating for the company in a research report on Monday, August 4th. Three equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $28.89.

Baxter International Company Profile

Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.

Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.